Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-041953

Chief Scientific Officer acquired 3,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Biller Scott · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-06-23 Exercise or conversion : show line 1 in the form +3,000 $0.47 $1,403 6,264 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-06-23 Exercise or conversion : show line 2 in the form Stock option (right to buy) −3,000 14,875 D
Loading xslF345X03/doc4.xml…